Thomas Strüngmann
Thomas Strüngmann (born 1950) founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February he and his brother Andreas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion.
See also
External links
Authority control  |
|---|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.